Login / Signup

Symptom severity is a major determinant of cannabis-based products use among people with multiple sclerosis.

Tangui BarréDamien TestaMelina SantosFabienne MarcellinPerrine RouxPatrizia CarrieriLise RadoszyckiCamelia Protopopescu
Published in: Journal of clinical nursing (2023)
This study highlights the characteristics of MS patients using CBP. Such practices should be discussed by healthcare professional with MS patients.
Keyphrases
  • multiple sclerosis
  • healthcare
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • mass spectrometry
  • peritoneal dialysis
  • ms ms
  • patient reported
  • social media
  • health information
  • health insurance